申请人:Cancer Research Technology Limited
公开号:US20160102094A1
公开(公告)日:2016-04-14
The present application provides a compound of formula (1)
or a salt thereof, wherein R
7
, R
8
, R
9
, G, and X are as defined herein. This application further describes compositions comprising the same. Compounds of formula (I) and their salts have aPKC inhibitory activity, and may be used to treat proliferative diseases.
本申请提供了一个公式(1)的化合物或其盐,其中R7、R8、R9、G和X的定义如本文所述。本申请进一步描述了包含这些化合物的组合物。公式(I)的化合物及其盐具有aPKC抑制活性,并可用于治疗增殖性疾病。